Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GBR1302 |
Trade Name | |
Synonyms | GBR 1302|GBR-1302 |
Drug Descriptions |
GBR1302 is a bispecific antibody that targets both ERBB2 (HER2) and CD3, which may have anti-tumor activity against ERBB2 (HER2)-positive tumors (European Journal of Cancer, Vol. 50, 48 (abst nr. 139), PMID: 32054397). |
DrugClasses | CD3 Antibody 99 HER2 (ERBB2) Antibody 76 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GBR1302 | GBR1302 | 0 | 2 |